Delivery Strategies for mRNA Vaccines.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 1, p. 11, doi. 10.1007/s40290-021-00417-5
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2022 AND VI 36 AND IP 1
Results: 6
1
2
Major Pharmaceutical Conferences and Courses: April to May 2022.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 1, p. 59, doi. 10.1007/s40290-021-00416-6
- Publication type:
- Article
3
Digital Additional Risk Minimization Measures: An Exploratory Study Using Qualitative Feedback from Healthcare Professionals and Patients Across Six Countries.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 1, p. 21, doi. 10.1007/s40290-021-00415-7
- By:
- Publication type:
- Article
4
Impact of Changing Regulations and the Dynamic Nature of European Risk Management Plans for Human Medicines on the Lifecycle of Safety Concerns.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 1, p. 33, doi. 10.1007/s40290-021-00414-8
- By:
- Publication type:
- Article
5
Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 1, p. 47, doi. 10.1007/s40290-021-00413-9
- By:
- Publication type:
- Article
6
Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 1, p. 1, doi. 10.1007/s40290-021-00412-w
- By:
- Publication type:
- Article